{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-097506","form_type":"8-K","ticker":"ESPR","cik":"0001434868","company_name":"Esperion Therapeutics, Inc.","filed_at":"2025-10-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.405080+00:00","generated_at":"2026-05-17T04:25:10.502518+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"low","headline":"Esperion posts updated corporate presentation; no specific details provided","bullets":["Company filed 8-K noting October 2025 corporate presentation posted to investor page.","Exhibit 99.1 is the corporate presentation, but its content was not disclosed in this filing.","No financial or strategic updates are available from the filing text or exhibit excerpt.","Investors should review the presentation at esperion.com/investors-media for material information."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-097506","json":"https://secwatch.observer/filing/0001104659-25-097506.json","markdown":"https://secwatch.observer/filing/0001104659-25-097506.md","text":"https://secwatch.observer/filing/0001104659-25-097506.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434868/000110465925097506/0001104659-25-097506-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434868/000110465925097506/tm2527818d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:25:10.502518+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}